The University of Chicago Header Logo

Connection

James Howard Tonsgard to Sirolimus

Back to Details
This is a "connection" page, showing publications James Howard Tonsgard has written about Sirolimus.
James Howard Tonsgard
Connection Strength
0.100
Sirolimus
  1. Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study. Neuro Oncol. 2015 Apr; 17(4):596-603.
    View in: PubMed
    Score: 0.100
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.